BPC-157/TB500 10MG

BPC-157/TB-500 is a two-peptide combination formulation supplied as one lyophilized vial, pairing BPC-157, a synthetic 15-amino-acid fragment of human gastric protein BPC, with TB-500 (Thymosin Beta-4), a 43-amino-acid actin-sequestering peptide. The two are among the most frequently cited compounds in tissue-repair, cell-migration, and angiogenesis research, and are commonly studied side by side. Because it is a blend, it has no single molecular weight or molar equivalent — those figures apply to the individual components rather than to the product as a whole.

This vial contains 10mg of total peptide mass as a lyophilized powder (5mg BPC-157 and 5mg TB-500). The figure refers to the combined content of both components, not to either one alone.

• Vial contents: 10mg lyophilized powder (batch BPCTB-010-260803-L001 tested at 13.01mg total)
• Components (labeled): BPC-157 5mg, TB-500 (TB-4) 5mg — measured at BPC-157 6.73mg and Thymosin Beta-4 6.28mg on the batch COA
• Molar content: Not applicable as a blend — approximately 3.52 µmol BPC-157 and 1.01 µmol TB-500 per vial (based on labeled mass)
• Molecular weight: Not applicable — blend, not a single chemical entity (BPC-157 1419.6 g/mol; Thymosin Beta-4 4963.5 g/mol)
• Classification: Two-peptide combination formulation
• Sequence: BPC-157: GEPPPGKPADDAGLV; Thymosin Beta-4: Ac-SDKPDMAEIEKFDKSKLKTETQEKNPLPSKETIEQEKQAGES
• Purity: 99.97% by HPLC-UV, identity confirmed by LC-MS (batch BPCTB-010-260803-L001) — see COA

For laboratory research use only. Not for human or veterinary use.